4.6 Article

Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses

Journal

PLOS ONE
Volume 9, Issue 10, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0111351

Keywords

-

Funding

  1. Department of Biotechnology India, Indian Institute of Science Education and Research-Kolkata (IISER-K), India [BT/PR14260/MED/30/437/2010]
  2. NIH [EY015014]
  3. ASM-IUSSTF Indo-US Research Professorship Award
  4. University Grant Commission (UGC), India

Ask authors/readers for more resources

Neurotropic recombinant strain of Mouse Hepatitis Virus, RSA59, induces meningo-encephalitis, myelitis and demyelination following intracranial inoculation. RSA59 induced neuropathology is partially caused by activation of CNS resident microglia, as demonstrated by changes in cellular morphology and increased expression of a microglia/macrophage specific calcium ion binding factor, Iba1. Affymetrix Microarray analysis for mRNA expression data reveals expression of inflammatory mediators that are known to be released by activated microglia. Microglia-specific cell surface molecules, including CD11b, CD74, CD52 and CD68, are significantly upregulated in contrast to CD4, CD8 and CD19. Protein analysis of spinal cord extracts taken from mice 6 days post-inoculation, the time of peak inflammation, reveals robust expression of IFN-gamma, IL-12 and mKC. Data suggest that activated microglia and inflammatory mediators contribute to a local CNS microenvironment that regulates viral replication and IFN-gamma production during the acute phase of infection, which in turn can cause phagolysosome maturation and phagocytosis of the myelin sheath, leading to demyelination.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Serum exosomes and cytokines promote a T-helper cell type 2 environment in the peripheral blood of glioblastoma patients

Larry A. Harshyne, Brian J. Nasca, Lawrence C. Kenyon, David W. Andrews, D. Craig Hooper

NEURO-ONCOLOGY (2016)

Article Immunology

Demyelinating strain of mouse hepatitis virus infection bridging innate and adaptive immune response in the induction of demyelination

Kaushiki Biswas, Dhriti Chatterjee, Sankar Addya, Reas S. Khan, Lawrence C. Kenyon, Alexander Choe, Randall J. Cohrs, Kenneth S. Shindler, Jayasri Das Sarma

CLINICAL IMMUNOLOGY (2016)

Article Clinical Neurology

Intraosseous hemangioblastoma of the cervical spine: case report

Zhenteng Li, Brian Curtis, Robert Layser, Santosh Kumar Selvarajan, James Harrop, Lawrence C. Kenyon, Theodore Parsons, Asa Rubin

JOURNAL OF NEUROSURGERY-SPINE (2017)

Article Multidisciplinary Sciences

Aspirin induces cell death by directly modulating mitochondrial voltage-dependent anion channel (VDAC)

Debanjan Tewari, Dhriti Majumdar, Sirisha Vallabhaneni, Amal Kanti Bera

SCIENTIFIC REPORTS (2017)

Article Cell & Tissue Engineering

Systemic Factors Trigger Vasculature Cells to Drive Notch Signaling and Neurogenesis in Neural Stem Cells in the Adult Brain

Ruihe Lin, Jingli Cai, Lawrence Kenyon, Renato Iozzo, Robert Rosenwasser, Lorraine Iacovitti

STEM CELLS (2019)

Article Biochemistry & Molecular Biology

A proline insertion-deletion in the spike glycoprotein fusion peptide of mouse hepatitis virus strongly alters neuropathology

Manmeet Singh, Abhinoy Kishore, Dibyajyoti Maity, Punnepalli Sunanda, Bankala Krishnarjuna, Sreeparna Vappala, Srinivasarao Raghothama, Lawrence C. Kenyon, Debnath Pal, Jayasri Das Sarma

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Article Immunology

Rheumatoid meningitis sine arthritis

Cathy Lee Ching, Lawrence Kenyon, Matthew Berk, Chantel Park

JOURNAL OF NEUROIMMUNOLOGY (2019)

Article Cell Biology

Intracranial cellular schwannomas: a clinicopathological study of 20 cases

Felipe D'Almeida Costa, Tiago M. Dias, Kara A. Lombardo, Aditya Raghunathan, Caterina Giannini, Lawrence Kenyon, Ali G. Saad, Murat Gokden, Peter C. Burger, Elizabeth A. Montgomery, Fausto J. Rodriguez

HISTOPATHOLOGY (2020)

Article Clinical Neurology

Cell Senescence and Cerebral Small Vessel Disease in the Brains of People Aged 80 Years and Older

Emma J. Norton, Leslie R. Bridges, Lawrence C. Kenyon, Margaret M. Esiri, Dorothy C. Bennett, Atticus H. Hainsworth

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2019)

Article Virology

CD4 Deficiency Causes Poliomyelitis and Axonal Blebbing in Murine Coronavirus-Induced Neuroinflammation

Debanjana Chakravarty, Fareeha Saadi, Soumya Kundu, Abhishek Bose, Reas Khan, Kimberly Dine, Lawrence C. Kenyon, Kenneth S. Shindler, Jayasri Das Sarma

JOURNAL OF VIROLOGY (2020)

Article Oncology

Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma

David W. Andrews, Kevin D. Judy, Charles B. Scott, Samantha Garcia, Larry A. Harshyne, Lawrence Kenyon, Kiran Talekar, Adam Flanders, Kofi-Buaku Atsina, Lyndon Kim, Nina Martinez, Wenyin Shi, Maria Werner-Wasik, Haisong Liu, Mikhail Prosniak, Mark Curtis, Rhonda Kean, Donald Y. Ye, Emily Bongiorno, Sami Sauma, Mark A. Exley, Kara Pigott, D. Craig Hooper

Summary: IGV-001 demonstrated good tolerability in newly diagnosed glioblastoma patients, with a significantly improved median progression-free survival (PFS) compared to standard of care (SOC). In patients eligible for Stupp criteria, IGV-001 showed positive outcomes in terms of PFS and overall survival, suggesting a potential immune-mediated mechanism.

CLINICAL CANCER RESEARCH (2021)

Article Immunology

Systemic Immune Bias Delineates Malignant Astrocytoma Survival Cohorts

Michael Prosniak, Larry A. Harshyne, Jonathan Gorky, Mark T. Curtis, Lawrence C. Kenyon, James S. Schwaber, Aurore Lebrun, Rhonda B. Kean, David W. Andrews, D. Craig Hooper

Summary: Patients with grade III anaplastic astrocytomas (AA) can be categorized into distinct immune bias profiles based on the presence or absence of mutations in isocitrate dehydrogenase (IDH). Two different immune biases were identified in patients with different IDH mutational status, with type 2 bias more common in IDH wild-type AA and type 1 bias more common in patients with IDH1R132H mutation. Additionally, the patient's immune profile was found to be more closely associated with tumor vascular enhancement on imaging rather than IDH mutational status.

JOURNAL OF IMMUNOLOGY (2021)

Article Clinical Neurology

Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells

Michael Prosniak, Lawrence C. Kenyon, D. Craig Hooper

Summary: The difficulty in treating glioblastoma comes from its infiltrative growth and a population of therapy-resistant cells. By analyzing the expression of protein markers in tumor specimens, cells more likely to have these properties can be identified.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2021)

Article Clinical Neurology

Pilocytic astrocytoma harboring a novel GNAI3-BRAF fusion

Ruihe Lin, Alicia Kenyon, Zi-Xuan Wang, Jingli Cai, Lorraine Iacovitti, Lawrence C. Kenyon

Summary: Pilocytic astrocytoma (PA), a low-grade tumor of the central nervous system, often seen in children or young adults, has been found to have unique molecular findings through next-generation sequencing. Among the genetic abnormalities identified, BRAF alterations, particularly BRAF fusions, play a significant role in the tumorigenesis of PAs.

NEUROPATHOLOGY (2023)

No Data Available